K. Leigh Greathouse

Cancer biologist/dietitian | cancer survivor | developing dietary and microbial tools to improve cancer treatment | #MentorFirst | Associate Prof | @Baylor

[Dr. Arthur Brooks @arthurbrooks]

Graduation looks like an ending — it really isn't. It's the start of a harder, more important question: not just what they're going to do, but what their life is actually for. I’ve been thinking about that a lot in recent years, and it's part of why I wrote my new book, The Meaning of Your Life.

If you have a graduate in your life and you’re looking for something worth giving them, consider getting them a copy.

[Paul S. Conyngham @paul_conyngham]

https://t.co/bpa3HHt8Mg

[K. Leigh Greathouse @CancerMicrobes]

NIH pivots away from agency-directed science https://t.co/3gIcq5WH3e

[K. Leigh Greathouse @CancerMicrobes]

So proud of my amazing colleague and her awesome products!!!

Primal Health Wants to Transform Oral Health https://t.co/pOYC9meENz via @tcbmag

[S.E. Robinson, Jr. @SERobinsonJr]

xAI NEWS: Paul Conyngham, a Sydney-based tech entrepreneur and AI consultant, used Grok to finalize a mRNA vaccine construct for his dog Rosie's mast cell cancer.

Paul used three AI models. He combined ChatGPT for initial ideas, AlphaFold for mutation analysis, and Grok took the mutation data and other inputs to create the final sequence for the custom mRNA vaccine targeting those exact mutations.

Paul sequenced Rosie's healthy DNA and the tumor DNA for $3,000 at the University of New South Wales' (UNSW) Ramaciotti Research Centre, in Sydney, Australia.

He partnered with researchers like Prof. Pall Thordarson and Prof. Martin Smith for manufacturing and injection.

They reported a 75% shrinkage in one tumor.

[DWeissLab @DWeissLab]

So thrilled this story is now published! Huge thank you to @PLOSBiology!

@grakoui @anuradhaiitm

[Pan Lu @lupantech]

Introducing Eubiota: A multi-agent AI framework for autonomous discovery in the human microbiome. 🧬🤖🧫

👇 Explore the platform:
https://t.co/fWzsWyKQs7

Eubiota doesn’t just chat: it plans, uses tools, verifies evidence, and drives end-to-end discovery—from hypothesis to wet-lab validation.

Eubiota achieved 87.7% accuracy on mechanistic reasoning (vs. GPT-5.1 77.3%).

But we went further. We used Eubiota to drive 4 discoveries with experimental validation:

✅ Gene Discovery: Identified the uvr-ruv stress axis by screening 1,945 genes & 10K papers in hours (on 2 GPUs) 🧬⚡
✅ Therapeutics: Designed a microbial therapy that reduced colitis inflammation 🦠💊
✅ Antibiotics: Engineered a cocktail that kills pathogens but spares commensals 🎯🛡️
✅ Metabolites: Discovered novel anti-inflammatory molecules from large human data 🥗🧪

📄 Paper: https://t.co/Ns9sOkQTlR
💻 Code: https://t.co/sseUyrBd15

Try the live app to start your own discovery:
🎮 App: https://t.co/8yanZj0vZC

Huge thanks to fantastic co-lead @YifanGao15, our incredible PIs @james_y_zou @LabSonnenburg, stellar advisors Kerwyn Casey Huang, @YejinChoinka, and the excellent team! 👏

#Eubiota #Microbiome #Inflammation #AI4Sci #AgenticAI #Agent

[K. Leigh Greathouse @CancerMicrobes]

@lupantech Thanks for this amazing resource! Great work!

[K. Leigh Greathouse @CancerMicrobes]

Super excited to finally share my TEDx talk! Hope it provides inspiration!

God is great!

https://t.co/1HZPevsJ6D

[K. Leigh Greathouse @CancerMicrobes]

Super excited to finally share my TEDx talk! Hope it provides inspiration!

God is great!

https://t.co/1HZPevsJ6D

[nature @Nature]

These lab hacks might make your science easier in 2026

https://t.co/3HxrzIpjw7

[Roth_Lab @Roth_Lab]

Excited to present the first major work after starting our lab at Stanford and the Arc this year: CRISPR-All, a unified genetic perturbation language for programming any major type of genetic perturbation simultaneously, in any combination, at genome scale, in human cells.

[K. Leigh Greathouse @CancerMicrobes]

Wanted to share something I have been pondering quite a bit lately, and eventually hope to write a book on this subject.

What examples do you have of individuals that have achieved excellence in their field while leaving margin to sustain and cultivate the relationships around them?

https://t.co/nWj8wxIHM1

[K. Leigh Greathouse @CancerMicrobes]

Happy #VeteransDay 's Day! Thank you to my wonderful husband for your 17 years of service to this country…and 25 years of marriage!

[K. Leigh Greathouse @CancerMicrobes]

Excited to share my story on @Baylor @TEDx this past Saturday
Check it out here (mark 48:07)
TEDxBaylor University: Innovation in Deeds (Session 1) https://t.co/1BghIXEjbm via @YouTube

[K. Leigh Greathouse @CancerMicrobes]

Friday night fun with the @greathouselab first Pizza Off!
Big shout out to Colin for putting it together and being the first place winner 🏆
It was awesome 🙌

[Cold Spring Harbor Laboratory @CSHL]

It is with sadness that we acknowledge the passing of Dr. James Watson, Nobel prize-winning scientist and former Director and President of CSHL. We extend our sincere condolences to his wife Liz and family during this difficult time. We recognize Dr. Watson’s incredible contributions to science and the research community. More on Dr. Watson’s legacy with CSHL can be found on our website. https://t.co/s6ZWiP621D

[K. Leigh Greathouse @CancerMicrobes]

Excited to be sharing my story about how "Cancer gave me superpowers" at the @Baylor @TEDx event on November 8th!
Livestream starts at 9:30 AM CST
https://t.co/laMOZ4C2F2

[K. Leigh Greathouse @CancerMicrobes]

@sweatystartup Highly recommend https://t.co/WXDQN2TEFR

[Mossad Commentary @MOSSADil]

🚨 BREAKTHROUGH IN ISRAELI MEDICINE

For the first time in Israel, doctors at Kaplan Medical Center have successfully implanted an EndoArt artificial cornea, a revolutionary Israeli-made device that restores sight without requiring a human donor.

🔹 The patient had suffered from severe corneal edema and rejected 3 previous donor transplants.
🔹 The EndoArt, developed by EyeYon Medical, replaces the cornea’s inner layer with a thin, bioinert film that’s not rejected by the body.
🔹 The result: restored vision, zero donor tissue, and new hope for thousands on transplant waiting lists.
Prof. Arie Marcovich called it “a real breakthrough that gives hope to patients who’ve exhausted all options.”

🇮🇱 Once again — Israeli innovation is changing lives and leading global medicine.

Stay connected, follow @MOSSADil.